Sickle Cell Disease in Babies
The short answer
Sickle cell disease (SCD) is an inherited blood disorder where red blood cells become rigid and sickle-shaped, blocking blood flow and causing pain and organ damage. It affects approximately 1 in 365 African American births and also occurs in Hispanic, Mediterranean, Middle Eastern, and South Asian populations. Detected through newborn screening, early treatment with penicillin prophylaxis and comprehensive care has dramatically improved outcomes.
By Age
What to expect by age
Babies with sickle cell disease are usually symptom-free at birth because they still have protective fetal hemoglobin. The condition is detected through the newborn screening blood test. Once diagnosed, babies are started on daily penicillin by 2 months of age to prevent life-threatening pneumococcal infections. Establishing care with a pediatric hematologist early is essential.
As fetal hemoglobin levels drop and are replaced by sickle hemoglobin, the first symptoms may appear. Dactylitis — painful swelling of the hands and feet — is often the earliest sign, along with fussiness and irritability. Babies may also develop mild jaundice or pallor from chronic anemia. Keep up with the daily penicillin and all vaccination schedules, as children with SCD are at high risk for serious infections.
This is a vulnerable period as fetal hemoglobin continues to decline. Babies may experience pain episodes, splenic sequestration (sudden pooling of blood in the spleen causing rapid anemia), and increased infection risk. Parents should learn to feel the spleen and recognize signs of splenic sequestration (sudden pallor, irritability, enlarged belly). Fever above 101.3°F (38.5°C) is always an emergency in a baby with SCD.
Toddlers with SCD may have recurrent pain crises, delayed growth, and frequent infections despite preventive measures. Many children are started on hydroxyurea, which increases fetal hemoglobin production and significantly reduces complications. Newer treatments including L-glutamine, crizanlizumab, and gene therapy are expanding options. With comprehensive care, children with SCD can thrive.
What Should You Do?
When to take action
- Your baby has sickle cell trait (carrier status) rather than sickle cell disease — carriers are generally healthy
- Your baby with SCD is on prophylactic penicillin, vaccinated, and growing well
- Mild jaundice in a baby with SCD that is being monitored by their hematology team
- Your baby with SCD is meeting developmental milestones appropriately
- Your baby with SCD is having more frequent pain episodes or seems increasingly irritable
- Your baby with SCD appears paler than usual or has increasing jaundice
- Your baby's newborn screening shows sickle cell trait and you want to understand what this means for your family
- Your baby with SCD has a fever of 101.3°F (38.5°C) or higher — this is always an emergency requiring immediate medical evaluation and antibiotics
- Your baby with SCD suddenly becomes very pale, limp, or has a rapidly enlarging abdomen — this may indicate splenic sequestration, a life-threatening emergency
Sources
Related Resources
Related Medical Concerns
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Air Quality and Baby Health
Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.
Altitude Sickness in Babies
Babies and toddlers can experience altitude sickness when traveling above 5,000-8,000 feet (1,500-2,500 meters). Symptoms are harder to recognize in infants because they cannot describe how they feel. Watch for unusual fussiness, poor feeding, disrupted sleep, vomiting, and fast breathing. Gradual ascent is the best prevention. Most pediatricians recommend avoiding sleeping at very high altitudes (above 8,000 feet) with infants when possible, and descending immediately if symptoms appear.
Amblyopia (Lazy Eye) Treatment Timing
Amblyopia (lazy eye) is the most common cause of vision loss in children, affecting 2-3% of the population. It occurs when one eye develops weaker vision because the brain favors the other eye. Early detection and treatment are critical because the visual system is most responsive to treatment during early childhood. Treatment is most effective when started before age 7, though improvement is possible at older ages. Treatment options include patching the stronger eye, atropine eye drops, glasses, or a combination.